Table 2 Annual Percent Changes (APC), and corresponding 95% Confidence Intervals (CI), of selected cancers by sex according to age groups, during the period 1996-2010, Sétif Cancer Registry
From: Time trends of cancer incidence in Setif, Algeria, 1986–2010: an observational study
Cancer or group of cancers | All Ages | 15-44 years | 45-64 years | 65+ years | ||||
|---|---|---|---|---|---|---|---|---|
APC | 95% CI | APC | 95% CI | APC | 95% CI | APC | 95% CI | |
Men | ||||||||
Nasopharynx | -3.4* | (-5.1;-1.6) | -4.9* | (-8.5;-1.1) | -4.0* | (-6.8;-1.1) | -2.4 | (-9.8;+5.6) |
Stomach | -1.1 | (-2.7;+0.6) | -7.0* | (-12.0;-1.8) | -2.0 | (-5.9;+2.2) | +2.7 | (-0.6;+6.1) |
Colon-rectum | +5.4* | (+3.4;+7.6) | -0.8 | (-4.7;+3.3) | +3.7* | (+0.5;+7.0) | +11.1* | (+6.5;+15.8) |
Liver | +8.9* | (+0.9;+17.5) | +3.6 | (-13.8;+24.6) | +1.6 | (-7.8;+12.1) | +9.6 | (-0.4;+20.6) |
Gallbladder | +1.0 | (-5.2;+7.6) | -4.3 | (-15.3;+8.0) | -0.2 | (-8.2;+8.5) | +3.3 | (-4.8;+12.1) |
Larynx | +1.0 | (-4.8;+7.1) | +4.7 | (-5.9;+16.4) | -4.8 | (-10.8;+1.6) | +5.1 | (-0.9;+11.4) |
Lung | +1.8* | (+0.0;+3.6) | +4.7 | (-3.8;+14.0) | +0.7 | (-1.6;+3.1) | +2.8* | (+0.3;+5.4) |
Prostate | +4.3* | (+2.0;+6.8) | +1.0 | (-18.4;+25.0) | +0.9 | (-3.7;+5.8) | +5.0* | (+1.7;+8.5) |
Kidney | +4.3 | (-1.1;+10.0) | +0.6 | (-14.8;+18.7) | +2.0 | (-5.5;+10.1) | -0.6 | (-10.6;+10.6) |
Bladder | +5.9* | (+4.1;+7.7) | +7.4 | (-1.1;+16.5) | +3.5* | (+0.4;+6.6) | +8.0* | (+4.7;+11.5) |
Thyroid | +3.2 | (-3.6;+10.5) | +0.1 | (-7.6;+8.5) | -0.2 | (-9.1;+9.6) | +2.6 | (-7.2;+13.5) |
Hodgkin lymphoma | -0.6 | (-7.8;+7.2) | +1.2 | (-6.6;+9.6) | -1.9 | (-11.1;+8.4) | +5.4 | (-8.0;+20.8) |
Non Hodgkin lymphomas | +0.8 | (-3.3;+5.0) | +2.3 | (-2.8;+7.7) | -1.8 | (-8.4;+5.4) | +4.4 | (-2.7;+11.9) |
Leukaemias | +6.7 | (-0.4;+14.2) | +13.7* | (+6.8;+21.0) | +3.0 | (-3.0;+9.4) | +6.0 | (-4.2;+17.2) |
Unspecified and ill-defined cancers | +0.5 | (-4.2;+5.5) | -0.6 | (-9.1;+8.6) | -1.1 | (-6.5;+4.6) | +4.4 | (-1.7;+10.9) |
All cancers but skin | +2.5* | (+1.6;+3.4) | +1.5 | (-0.4;+3.4) | +0.9 | (-0.4;+2.2) | +5.1* | (+3.8;+6.4) |
Women | ||||||||
Nasopharynx | +2.5 | (-1.6;+6.7) | -0.7 | (-6.1;+4.9) | +5.5 | (-1.6;+13.1) | +0.0 | (-6.7;+7.1) |
Stomach | +0.6 | (-1.7;+2.9) | -6.6* | (-12.4;-0.4) | +0.3 | (-4.5;+5.4) | +3.3 | (-1.8;+8.6) |
Colon-rectum | +4.5* | (+1.6;+7.4) | -2.1 | (-6.3;+2.3) | +5.3* | (+1.4;+9.3) | +7.5* | (+3.8;+11.3) |
Liver | +5.4* | (+0.2;+10.8) | +6.6 | (-6.0;+20.8) | +5.3 | (-2.5;+13.8) | +3.1 | (-4.0;+10.8) |
Gallbladder | -3.2* | (-5.8;-0.5) | -8.7* | (-14.5;-2.5) | -2.8 | (-5.8;+0.4) | -2.1 | (-6.6;+2.7) |
Larynx | +13.8* | (+0.6;+28.7) | +22.8 | (-1.3;+52.9) | +6.7 | (-7.7;+23.3) | +5.4 | (-9.9;+23.2) |
Lung | +10.0* | (+5.9;+14.2) | +6.2 | (-0.8;+13.6) | +10.4* | (+3.2;+18.1) | +7.8* | (+2.8;+13.1) |
Breast | +8.2* | (+5.7;+10.7) | +9.7* | (+5.8;+13.7) | +7.3* | (+4.8;+9.9) | +6.9* | (+1.9;+12.2) |
Cervix uteri | -4.2* | (-6.6;-1.7) | -1.8 | (-5.7;+2.3) | -5.9* | (-9.4;-2.3) | -0.6 | (-4.5;+3.4) |
Ovary | -2.1 | (-6.7;+2.8) | -0.0 | (-6.1;+6.4) | -7.5* | (-11.5;-3.3) | +0.8 | (-5.1;+6.9) |
Kidney | -3.4 | (-11.1;+4.9) | +0.1 | (-12.7;+14.7) | -0.9 | (-6.7;+5.2) | +5.1 | (-9.4;+22.1) |
Bladder | -4.4 | (-15.4;+8.0) | +0.1 | (-21.8;+28.1) | -10.4 | (-26.3;+9.0) | +4.0 | (-5.2;+14.1) |
Thyroid | +5.3* | (+2.8;+7.9) | +9.8* | (+5.6;+14.2) | +5.0* | (+1.8;+8.4) | -0.8 | (-5.3;+3.8) |
Hodgkin lymphoma | +4.7 | (-1.3;+11.1) | +3.2 | (-1.6;+8.3) | -1.2 | (-9.3;+7.6) | +23.9 | (-4.1;+59.9) |
Non Hodgkin lymphomas | +2.9 | (-1.0;+6.9) | +6.3* | (+0.9;+12.0) | +4.1 | (-1.1;+9.6) | -2.1 | (-8.1;+4.3) |
Leukaemias | +3.1 | (-3.9;+10.6) | +11.2* | (+2.9;+20.1) | -0.1 | (-7.4;+7.8) | +3.6 | (-5.3;+13.4) |
Unspecified and ill-defined cancers | -0.4 | (-5.9;+5.4) | -5.4 | (-11.0;+0.6) | -3.2 | (-9.1;+3.0) | +4.6 | (-2.8;+12.7) |
All cancers but skin | +3.7* | (+2.6;+4.8) | +5.2* | (+3.1;+7.4) | +2.8* | (+1.6;+4.0) | +4.4* | (+2.5;+6.4) |